Under the deal, AbbVie agreed to lower prices on certain Medicaid drugs and expand distribution via the TrumpRx direct-to-patient platform.

TopGum's acquisition marks its entry into pharmaceutical manufacturing, with a focus on gummy dosage forms containing active pharmaceutical ingredients. The acquisition includes a U.S. manufacturing ...

This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing collapsed. More than 320 ...

CHICAGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / July 14, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a bio-pharmaceutical company focused on developing, manufacturing, and marketing complex generic ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a ...

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity at ...

Genentech, considered one of the biotech industry’s founding companies, announced in May 2025 that it planned to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs and ...

Leading drug maker Sun Pharmaceutical will invest ₹500 crore to set up a manufacturing plant in Assam, generating direct employment for over 500 people, Chief Secretary Ravi Kota said. Senior ...